Dr. John Cush RheumNow
3 years 6 months ago
We're less than 3 weeks out from RheumNow Live. Are you coming? We'll be hosting a variety of topic panels, including one focused on Spondyloarthritis Innovations. Join us!
https://t.co/AOJGKTss7Q https://t.co/7nCdgwO6Zh
Dr. John Cush RheumNow
3 years 6 months ago
VTE Options
QD Clinic - Lessons from the clinic, brought to you by https://t.co/4UQlqwujiR March 18 &19, 2023 - Dallas, TX
https://t.co/xmtC8fvYUa https://t.co/FX6o35qwFW
Dr. John Cush RheumNow
3 years 6 months ago
Study of 78 pt suspected of #GCA undergoing Temp. artery Bx and US. Nearly half (35) Dx w/ GCA. Both had similar sensitivities(69% and 63%, respectively), but specificity higher w/ biopsy (100% vs 79%). Compression sign had best diagnostic performance https://t.co/ATPtN8WZin https://t.co/1MIrmp45AX
Most patients with psoriatic arthritis (PsA) failed to achieve low disease activity after switching from one targeted therapy to another, real-world data from Scandinavian registries indicated.
Dr. John Cush RheumNow
3 years 6 months ago
QD Clinic - Molly's in trouble
https://t.co/dTSHHlsCVD https://t.co/Vo9ZSHo5JB
Dr. John Cush RheumNow
3 years 6 months ago
In #RA, Citrullination modulates antigen processing and presentation by exposing otherwise cryptic epitopes https://t.co/aciZe4KG6H https://t.co/i7twPvb5P4
Dr. John Cush RheumNow
3 years 6 months ago
The Late Edition (2.24.2023)
This week’s reviews on the news and events from RheumNow.
https://t.co/44soaEGm5c https://t.co/1sBmKjDImE
Dr. John Cush RheumNow
3 years 6 months ago
Drs Schett & Mackensen reported a case of refractory inflammatory myositis successfully treated with CD19 CAR T cells. 41yoM w/ +Jo-1, myositis, ILD, Raynauds, periorb edema, not responding to steroids, RTX, IVIG, tacrolimus, CTX https://t.co/x2ljxNdXVM https://t.co/bVmQ0law5H
The Annals of Rheumatic Disease has published updated multinational, treat-to-target (T2T) recommendations for the treatment of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR).
Dr. John Cush RheumNow
3 years 6 months ago
Swedish registry of Axial SpA pregnancies, 1580 births (matched 1:10), saw improved Preg outcomes & incr biologic use. SpA pts had signif. incr in preterm (RR 1·43), preeclampsia (1·44), C-Sect (1·59), infant SIE (1·29) - Each decreased by annually 0.5% https://t.co/EAUwxNsgzH https://t.co/tmNi3dQtMK
Despite the encouraging phase II trial results of baricitinib in systemic lupus erythematosus (SLE) patients, two parallel phase III trials have failed to redemonstrate the efficacy of baricitinib in active SLE, thereby halting development of baricitinib in SLE.
Dr. John Cush RheumNow
3 years 6 months ago
Check out our latest podcast--The Late Edition.
https://t.co/DnIAuci11I https://t.co/Xd4tN5VajI
Dr. John Cush RheumNow
3 years 6 months ago
Periodontal Mucosal Breaks Trigger RA Disease Activity
Periodontal disease (PD) is more common in RA, especially those with anti-citrullinated protein antibodies (ACPAs). RA activity has been linked to the severity of PD and mucosal inflammation.
https://t.co/eTDNqlOHyp https://t.co/VZoeqJmsr0
